These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6170586)

  • 1. Interferon preparations and contaminating endotoxin.
    Fumarola D; Miragliotta G
    Infection; 1981; 9(5):255. PubMed ID: 6170586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the possible contamination of transfer factor preparations with bacterial endotoxins].
    Fumarola D; Panaro A
    Pathologica; 1976; 68(977-978):153-8. PubMed ID: 1018976
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicity of interferon.
    Priestman TJ; Lucken RN; Finter NB
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):562. PubMed ID: 6167311
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved method for the removal of endotoxin from DNA.
    Montbriand PM; Malone RW
    J Biotechnol; 1996 Jan; 44(1-3):43-6. PubMed ID: 8717385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of possible endotoxin contaminants present in some preparations of biological products and injectable drugs].
    Fumarola D
    Ann Sclavo; 1978; 20(4):546-57. PubMed ID: 380476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombogenic effects of some concentrates of coagulation factors: a possible role of contaminating endotoxin.
    Fumarola D
    Haematologica; 1978 Apr; 63(2):224. PubMed ID: 98405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible endotoxin contamination of erythropoietin preparations].
    Fumarola D; Palma R; Panaro A; Jirillo E
    Pathologica; 1977; 69(989-990):183-6. PubMed ID: 876694
    [No Abstract]   [Full Text] [Related]  

  • 8. A cell line assay system for predicting the response of human blood to endotoxin.
    Yamamoto A; Sakai T; Ochiai M; Kamachi K; Kataoka M; Toyoizumi H; Horiuchi Y
    Jpn J Infect Dis; 2003 Jun; 56(3):93-100. PubMed ID: 12944673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon: an early evaluation.
    McCredie KB; Moore MS
    J Okla State Med Assoc; 1980 Sep; 73(9):325-8. PubMed ID: 6160226
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyrogenicity versus endotoxicity: which is more significant?
    Shanbrom E
    Prog Clin Biol Res; 1982; 93():105-13. PubMed ID: 6181526
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible role of contaminating endotoxin in radiographic contrast media reactions.
    Fumarola D
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):848-9. PubMed ID: 552831
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon in human serum after injection of endotoxin.
    Sauter C; Wolfensberger C
    Lancet; 1980 Oct; 2(8199):852-3. PubMed ID: 6159510
    [No Abstract]   [Full Text] [Related]  

  • 14. Some comments on interferon.
    Gams RA
    Ala J Med Sci; 1980 Apr; 17(2):120-1. PubMed ID: 6158273
    [No Abstract]   [Full Text] [Related]  

  • 15. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials.
    Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW
    Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interferon].
    Schürmann W
    Krankenpfl J; 1981 Aug; 19(8):16-8. PubMed ID: 6169876
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon in Michigan.
    Rich J
    Mich Med; 1981 Aug; 80(23):402. PubMed ID: 6167843
    [No Abstract]   [Full Text] [Related]  

  • 18. Methods of endotoxin removal from biological preparations: a review.
    Magalhães PO; Lopes AM; Mazzola PG; Rangel-Yagui C; Penna TC; Pessoa A
    J Pharm Pharm Sci; 2007; 10(3):388-404. PubMed ID: 17727802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon: IFs and buts of cancer treatment.
    Iveson-Iveson J
    Nurs Mirror; 1980 Jul; 151(5):34-6. PubMed ID: 6157150
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of endogenous interferon on growth of malignant tumours in man.
    Babbar OP; Dhar MM; Kar AB; Mistra SC; Goel TC
    Indian J Exp Biol; 1971 Oct; 9(4):504-6. PubMed ID: 5147182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.